CNRI-LA, Pico Rivera CA   Report issue

For profit Phase 2
Founded: Pico Rivera CA United States (1991)
Status: Defunct (2016)

Organization Overview

First Clinical Trial
2008
NCT00734435
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Alternative names

CNRI

Active Ingredients

Drugs in Phase 2 Trials (3)

olanzapine (zyprexa) (1 trial)

rapastinel (1 trial)

zonisamide (Zonegran) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Depression (Phase 2)

Depressive Disorder (Phase 2)

Depressive Disorder, Major (Phase 2)

Disease (Phase 2)

Psychotic Disorders (Phase 2)

Schizophrenia (Phase 2)

Weight Gain (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 3